NCT01438229View on ClinicalTrials.gov

Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

July 31, 2014

Conditions
Hypertension
Interventions
DEVICE

St. Jude Medical renal artery ablation system: RF ablation generator (IBI 1500T11.5) and Renal artery ablation catheter (DS3D001, DS3D002)

Catheter-based RF ablation in renal artery

Trial Locations (4)

3168

Monash Medical Centre, Melbourne

5000

Royal Adelaide Hospital, Adelaide

5042

Flinders Medical Centre, Adelaide

Unknown

Hippokration Hospital, Athens

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT01438229 - Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients | Biotech Hunter | Biotech Hunter